🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 29273B021 (prev. 29273B104 )
- Market Cap
- Micro Cap
Business: ENDRA Life Sciences, Inc. is developing technology designed to increase the capabilities of clinical diagnostic ultrasound to broaden patient access to the safe diagnosis and treatment of a number of significant medical conditions in circumstances where expensive Xray computed tomography, or CT, and magnetic resonance imaging, or MRI, technology is unavailable or impractical.
Notes: December 5, 2022 -- ENDRA Life Sciences Inc. (NASDAQ: NDRA) (the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announced today that it will be effecting a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20. The reverse stock split will reduce the number of shares of the Company’s common stock outstanding from 63,174,455 shares to approximately 3,158,723 shares, subject to adjustment for the rounding up of fractional shares.
Company Contact
- CEO
- Alexander Tokman
- CFO
- Richard Jacroux
- Headquarters
- 3600 Green Court, Suite 350, Ann Arbor, MI 48105-1570
- Phone
- 734-335-0468
- Investor Relations
- Yvonne Briggs · 310-691-7100 · investors@endrainc.com